CoChat

P2X7 receptors exert a permissive effect on the activation of presynaptic AMPA receptors in rat trigeminal caudal nucleus glutamatergic nerve terminals

Open access
Currò, Diego, Navarra, Pierluigi, Samengo, Irene, Martire, Maria · 2020 · The Journal of Headache and Pain

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Abstract

Background: Purine receptors play roles in peripheral and central sensitization and are associated with migraine headache. We investigated the possibility that ATP plays a permissive role in the activation of AMPA receptors thus inducing Glu release from nerve terminals isolated from the rat trigeminal caudal nucleus (TCN). Methods: Nerve endings isolated from the rat TCN were loaded with [3 H]D-aspartic acid ([3 H]D-ASP), layered into thermostated superfusion chambers, and perfused continuously with physiological medium, alone or with various test drugs. Radioactivity was measured to assess [3 H]D-ASP release under different experimental conditions. Results: Synaptosomal [3 H]D-ASP spontaneous release was stimulated by ATP and to an even greater extent by the ATP analogue benzoylbenzoylATP (BzATP). The stimulation of [3 H]D-ASP basal release by the purinergic agonists was prevented by the selective P2X7 receptor antagonist A438079. AMPA had no effect on basal [3 H]D-ASP release, but the release observed when synaptosomes were exposed to AMPA plus a purinoceptor agonist exceeded that observed with ATP or BzATP alone. The selective AMPA receptor antagonist NBQX blocked this “excess” release. Co-exposure to AMPA and BzATP, each at a concentration with no release-stimulating effects, evoked a significant increase in [3 H]D-ASP basal release, which was prevented by exposure to a selective AMPA antagonist. Conclusions: P2X7 receptors expressed on glutamatergic nerve terminals in the rat TCN can mediate Glu release directly and indirectly by facilitating the activation of presynaptic AMPA receptors. The high level of glial ATP that occurs during chronic pain states can promote widespread release of Glu as well as can increase the function of AMPA receptors. In this manner, ATP contributes to the AMPA receptor activation involved in the onset and maintenance of the central sensitization associated with chronic pain.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s10194-020-01153-y

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Effects of purinergic receptor agonists on basal and 12 mM [K+]e-evoked [3H]D-ASP release from rat TCN synaptosomes. a Effects of ATP on basal and [K+]e-evoked release of [3H]D-ASP. Synaptosomes prelabeled with [3H]D-ASP were superfused with standard medium at a flow rate of 0.6 ml/min. At the beginning of min 38 (arrow), the medium was replaced with standard medium containing ATP (1 mM) or depolarizing medium (12 mM [K+]e) plus ATP (1 mM) (arrow) and perfusion continued for 4 min (i.e., minute 38 through min 41). Radioactivity in each fraction has been expressed as a percentage of the total radioactivity content present in the tissue at the onset of the fraction collected. Each point represents the mean ± S.E.M. of 3–4 different experiments, each run in triplicate (3 superfusion chambers for each condition). Error bars are absent when the S.E.M. was smaller than the symbol used in the graph. b Log concentration-response curves for BzATP in evoking [3H]D-ASP efflux and its Mg2+ sensitivity. BzATP (0.01–3 mM) was present in the standard perfusion medium for 4 min (min 38 through min 41). To assess the Mg2+–sensitivity of the effects of BzATP, synaptosomes were perfused for 18 min (min 20 through min 37) with standard medium in which the Mg2+ concentration had been reduced from 1.2 mmol/L to 0.01 mmol/L and then with the same medium containing BzATP (min 38 through min 41). The effects of the BzATP were expressed as percentage increases (ratio of the AUC observed in the presence of BzATP to the AUC for the release observed in the absence of the agonist). Data are means ± S.E.M. of at least 3 experiments, each run in triplicate. *P < 0.05 vs basal release. c Effects of ATP and BzATP on basal [3H]D-ASP release and their antagonism by A438079. A438079 (5 μM) was added to the perfusion medium 8 min before the agonists. ATP (1 mM) or BzATP (100 μM) was present in the standard perfusion medium (with or without A438079) for 4 min (minutes 38 through 41). Results are expressed as areas under the release/time-curves (AUCs). Each bar represents the mean ± SEM of 3 different experiments, each run in triplicate. *P < 0.05 vs basal release
Fig. 1 Effects of purinergic receptor agonists on basal and 12 mM [K+]e-evoked [3H]D-ASP release from rat TCN synaptosomes. a Effects of ATP on basal and [K+]e-evoked release of [3H]D-ASP. Synaptosomes prelabeled with [3H]D-ASP were superfused with standard medium at a flow rate of 0.6 ml/min. At the beginning of min 38 (arrow), the medium was replaced with standard medium containing ATP (1 mM) or depolarizing medium (12 mM [K+]e) plus ATP (1 mM) (arrow) and perfusion continued for 4 min (i.e., minute 38 through min 41). Radioactivity in each fraction has been expressed as a percentage of the total radioactivity content present in the tissue at the onset of the fraction collected. Each point represents the mean ± S.E.M. of 3–4 different experiments, each run in triplicate (3 superfusion chambers for each condition). Error bars are absent when the S.E.M. was smaller than the symbol used in the graph. b Log concentration-response curves for BzATP in evoking [3H]D-ASP efflux and its Mg2+ sensitivity. BzATP (0.01–3 mM) was present in the standard perfusion medium for 4 min (min 38 through min 41). To assess the Mg2+–sensitivity of the effects of BzATP, synaptosomes were perfused for 18 min (min 20 through min 37) with standard medium in which the Mg2+ concentration had been reduced from 1.2 mmol/L to 0.01 mmol/L and then with the same medium containing BzATP (min 38 through min 41). The effects of the BzATP were expressed as percentage increases (ratio of the AUC observed in the presence of BzATP to the AUC for the release observed in the absence of the agonist). Data are means ± S.E.M. of at least 3 experiments, each run in triplicate. *P < 0.05 vs basal release. c Effects of ATP and BzATP on basal [3H]D-ASP release and their antagonism by A438079. A438079 (5 μM) was added to the perfusion medium 8 min before the agonists. ATP (1 mM) or BzATP (100 μM) was present in the standard perfusion medium (with or without A438079) for 4 min (minutes 38 through 41). Results are expressed as areas under the release/time-curves (AUCs). Each bar represents the mean ± SEM of 3 different experiments, each run in triplicate. *P < 0.05 vs basal releaseCC BY · PubMed Central
Fig. 2 Effects of AMPA on basal and 12 mM [K+]e-evoked [3H]D-ASP release from rat TCN synaptosomes. a Effects of AMPA and antagonism by NBQX. Synaptosomes were prepared as previously described, and perfused for 37 min with standard medium. From min 38 through min 41, perfusion was carried out with standard medium containing 100 μM AMPA or depolarizing medium plus 100 μM AMPA. When used, the antagonist NBQX (10 μM) was added to the medium 8 min before AMPA. Each point represents the mean ± S.E.M. of 3–4 different experiments, each run in triplicate. b Cyclothiazide-sensitivity. The AMPA receptor desensitization inhibitor cyclothiazide (CTZ) (10 μM) was added concomitantly with AMPA (0.1–300 μM) to the depolarizing medium. The effects of the drugs on evoked release are expressed as percentage increases over values observed in the presence of the depolarizing stimulus alone. Data are means ± SEM of 3 experiments, each run in triplicate. *P < 0.05 vs [K+]e-evoked [3H]D-ASP release
Fig. 2 Effects of AMPA on basal and 12 mM [K+]e-evoked [3H]D-ASP release from rat TCN synaptosomes. a Effects of AMPA and antagonism by NBQX. Synaptosomes were prepared as previously described, and perfused for 37 min with standard medium. From min 38 through min 41, perfusion was carried out with standard medium containing 100 μM AMPA or depolarizing medium plus 100 μM AMPA. When used, the antagonist NBQX (10 μM) was added to the medium 8 min before AMPA. Each point represents the mean ± S.E.M. of 3–4 different experiments, each run in triplicate. b Cyclothiazide-sensitivity. The AMPA receptor desensitization inhibitor cyclothiazide (CTZ) (10 μM) was added concomitantly with AMPA (0.1–300 μM) to the depolarizing medium. The effects of the drugs on evoked release are expressed as percentage increases over values observed in the presence of the depolarizing stimulus alone. Data are means ± SEM of 3 experiments, each run in triplicate. *P < 0.05 vs [K+]e-evoked [3H]D-ASP releaseCC BY · PubMed Central
Fig. 3 Effects of AMPA and ATP (or BzATP) alone or in combination on basal [3H]D-ASP release: a Effects of AMPA and ATP alone or in combination on basal [3H]D-ASP release and their antagonism by NBQX. After 38 min of perfusion with standard medium, synaptosomes were exposed for 4 min to standard medium containing AMPA (100 μM), ATP (1 mM), or both drugs together. When used, the antagonist NBQX (10 μM) was added to the medium 8 min before the agonists. All results are expressed as areas under the release/time curves (AUCs). Each bar represents the mean ± SEM of 3 different experiments, each run in triplicate. *P < 0.05 vs basal release. **P < 0.01 vs basal release. b Effects of BzATP and AMPA alone or in combination and their antagonism by A438079 and by NBQX. The effects of BzATP were tested at two concentrations (10 and 100 μM), each in the presence or absence of AMPA (100 μM). Exposure times to agonists and antagonists (A438079 and NBQX) are those described in panel A. Each bar represents the mean ± SEM of 3 different experiments, each run in triplicate. *P < 0.05 vs basal release. **P < 0.01 vs basal release
Fig. 3 Effects of AMPA and ATP (or BzATP) alone or in combination on basal [3H]D-ASP release: a Effects of AMPA and ATP alone or in combination on basal [3H]D-ASP release and their antagonism by NBQX. After 38 min of perfusion with standard medium, synaptosomes were exposed for 4 min to standard medium containing AMPA (100 μM), ATP (1 mM), or both drugs together. When used, the antagonist NBQX (10 μM) was added to the medium 8 min before the agonists. All results are expressed as areas under the release/time curves (AUCs). Each bar represents the mean ± SEM of 3 different experiments, each run in triplicate. *P < 0.05 vs basal release. **P < 0.01 vs basal release. b Effects of BzATP and AMPA alone or in combination and their antagonism by A438079 and by NBQX. The effects of BzATP were tested at two concentrations (10 and 100 μM), each in the presence or absence of AMPA (100 μM). Exposure times to agonists and antagonists (A438079 and NBQX) are those described in panel A. Each bar represents the mean ± SEM of 3 different experiments, each run in triplicate. *P < 0.05 vs basal release. **P < 0.01 vs basal releaseCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 62 references

Cited by

See all 18

Metadata

Authors
Currò, D., Navarra, P., Samengo, I., & Martire, M.
Affiliations
Università Cattolica del Sacro Cuore (IT)
Corresponding author
Martire, Maria
Venue
The Journal of Headache and Pain
Published
2020-07-02
Volume
21
Issue
1
Pages
83-83
ISSN
  • 1129-2369 (ISSN-L)
  • 1129-2377
OpenAlex
W3039993279
Cited by
18
References
62
Citations by year
2026: 2 · 2025: 3 · 2024: 3 · 2023: 5 · 2022: 2 · 2021: 3
FWCI
1.57
Type
journal article
Language
en
Open access
Licence
Locations
  • The Journal of Headache and Pain (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • PubliCatt (Università Cattolica del Sacro Cuore) (submittedVersion, cc-by)
Funders
Fondi di Ateneo D1 2019 (R4124500867)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
Keywords
P2X7 receptor, ATP release, A438079, NBQX, central sensitization, chronic pain, migraine, purinergic signaling, synaptic transmission
MeSH terms
Animals, Male, Nerve Endings, Synaptic Transmission, Synaptosomes, Trigeminal Caudal Nucleus, Receptors, Presynaptic, Receptors, AMPA, Excitatory Amino Acid Antagonists, Rats, Receptors, Purinergic P2X7, Purinergic P2X Receptor Agonists, Purinergic P2X Receptor Antagonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: P2X7 receptors exert a permissive effect on the activation of presynaptic AMPA receptors in rat trigeminal caudal nucleus glutamatergic nerve terminals. https://app.cochat.ai/papers/10.1186/s10194-020-01153-y
The paper
Currò, D., Navarra, P., Samengo, I., & Martire, M. (2020). P2X7 receptors exert a permissive effect on the activation of presynaptic AMPA receptors in rat trigeminal caudal nucleus glutamatergic nerve terminals. The Journal of Headache and Pain. https://doi.org/10.1186/s10194-020-01153-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.